Version 2024

2024 ICD-10-CM Diagnosis Code G24.0

Drug induced dystonia

ICD-10-CM Code:
G24.0
ICD-10 Code for:
Drug induced dystonia
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Diseases of the nervous system
    (G00–G99)
    • Extrapyramidal and movement disorders
      (G20-G26)
      • Dystonia
        (G24)

G24.0 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of drug induced dystonia. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Drug induced dystonia

Non-specific codes like G24.0 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for drug induced dystonia:

  • Use G24.01 for Drug induced subacute dyskinesia - BILLABLE CODE

  • Use G24.02 for Drug induced acute dystonia - BILLABLE CODE

  • Use G24.09 for Other drug induced dystonia - BILLABLE CODE

Clinical Information

  • Dystonia

    an attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. it most often affects the large axial muscles of the trunk and limb girdles. conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as dystonic disorders. (adams et al., principles of neurology, 6th ed, p77)
  • Dystonia Musculorum Deformans

    a condition characterized by focal dystonia that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. the hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. onset is usually in the first or second decade. familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. (adams et al., principles of neurology, 6th ed, p1078)
  • Dystonic Disorders

    acquired and inherited conditions that feature dystonia as a primary manifestation of disease. these disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). they are also classified by patterns of inheritance and by age of onset.
  • Meige Syndrome

    a syndrome characterized by orofacial dystonia; including blepharospasm; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. it primarily affects older adults, with an incidence peak in the seventh decade of life. (from adams et al., principles of neurology, 6th ed, p108)
  • Nocturnal Paroxysmal Dystonia

    a parasomnia characterized by paroxysmal episodes of choreoathetotic, ballistic, dystonic movements, and semipurposeful activity. the episodes occur during non-rapid eye movement sleep and typically recur several times per night. (neurology 1992 jul;42(7 suppl 6):61-67; adams et al., principles of neurology, 6th ed, p391)
  • Tardive Dyskinesia

    drug-related movement disorder characterized by uncontrollable movements in certain muscles. it is associated with a long-term exposure to certain neuroleptic medications (e.g., metoclopramide).
  • Torticollis

    a symptom, not a disease, of a twisted neck. in most instances, the head is tipped toward one side and the chin rotated toward the other. the involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.
  • Metoclopramide

    a dopamine d2 antagonist that is used as an antiemetic.
  • ATP1A3 wt Allele|AHC2|ATP1A1|ATPase Na+/K+ Transporting Subunit Alpha 3 wt Allele|ATPase, Na(+)/K(+), Alpha III Gene|ATPase, Na+/K+ Transporting, Alpha 3 Polypeptide Gene|ATPase, Na+/K+ Transporting, Alpha-3 Polypeptide Gene|CAPOS|DYT12|Dystonia 12 Gene|Na+, K+ Activated Adenosine Triphosphatase Alpha Subunit 3 Gene|Na+, K+ Activated Adenosine Triphosphatase Alpha Subunit Gene|Na+/K+ ATPase 3 Gene|RDP|Sodium-Potassium-ATPase, Alpha 3 Polypeptide Gene|Sodium-Potassium-ATPase, Alpha-3 Polypeptide Gene

    human atp1a3 wild-type allele is located in the vicinity of 19q13.2 and is approximately 31 kb in length. this allele, which encodes sodium/potassium-transporting atpase subunit alpha-3 protein, plays a role in the exchange of sodium and potassium ions across the plasma membrane of neurons, resulting in a electrochemical gradient that promotes nutrient transport. mutation of the gene is associated with alternating hemiplegia of childhood 2, cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (capos) syndrome and dystonia type 12.
  • Autosomal Dominant Torsion Dystonia 1|DYT1

    an autosomal dominant inherited disorder caused by mutations in the tor1a gene. it usually begins in childhood or adolescence and is characterized by involuntary muscle contractions in the arms, legs, trunk, and neck.
  • Autosomal Recessive Torsion Dystonia 2|DYT2|Dystonia Musculorum Deformans 2

    an autosomal recessive inherited disorder caused by mutation in the hpca gene. it begins in childhood or adolescence and is characterized by involuntary, sustained muscle contractions and torsions affecting initially distal limbs and later the neck, orofacial, and craniocervical regions.
  • Dopamine Transporter Deficiency Syndrome|PKDYS|Parkinsonism-Dystonia, Infantile

    an autosomal recessive condition caused by mutation(s) in the slc6a3 gene, encoding sodium-dependent dopamine transporter. it is characterized by parkinsonian features and has an onset in early infancy.
  • Dopa-Responsive Dystonia|DYT5 Dystonia|Segawa's Disease

    a genetic disorder in females that presents in early childhood and is responsive to dopamine. it is characterized by clubfeet and parkinsonian symptoms that may progress from lower to upper extremities witha diurnal pattern, and involuntary muscle contractions and other uncontrolled movements in the lower limbs that worsen with excercise and improve with rest.
  • Dystonia

    a movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures.
  • Dystonia 12|DYT12|Rapid-Onset Dystonia-Parkinsonism

    an autosomal dominant condition caused by mutation(s) in the atp1a3 gene, encoding sodium/potassium-transporting atpase subunit alpha-3. it is characterized by abrupt onset of dystonia and parkinsonism in young adulthood, often triggered by physical or psychological stress.
  • Dystonia 16|DYT16

    an extremely rare autosomal recessive dystonia-parkinsonism condition caused by mutation(s) in the prkra gene encoding interferon-inducible double-stranded rna-dependent protein kinase activator a.
  • Dystonia Evaluation|DYSTONIA|Dystonia|Dystonia

    an evaluation of dystonia.
  • Dystonin|230 kDa Bullous Pemphigoid Antigen|230/240 kDa Bullous Pemphigoid Antigen|Bullous Pemphigoid Antigen|Bullous Pemphigoid Antigen 1|Bullous Pemphigoid Antigen 1, 230/240kDa|DST|Dystonia Musculorum Protein|Hemidesmosomal Plaque Protein|Trabeculin-Beta

    dystonin (7570 aa, ~860 kda) is encoded by the human dst gene. this protein plays a structural role in cytoskeleton networks.
  • Early Onset Primary Dystonia|Early Onset Torsion Dystonia|Early Onset Torsion Dystonia|Oppenheim's Dystonia|Oppenheim's Dystonia

    a genetic disorder that usually presents in early childhood and is characterized by muscle contractions in a foot, leg, or arm that gradually spreads to other body regions.
  • Episodic Kinesigenic Dyskinesia-1|DYT10|Dystonia 10|EKD1|PKD Dystonia|Paroxysmal Kinesigenic Dyskinesia

    an autosomal dominant condition caused by mutation(s) in the prrt2 gene, encoding proline-rich transmembrane protein 2. it is characterized by dyskinesia triggered by sudden movement. it shares features with infantile convulsions and paroxysmal choreoathetosis, familial. it is an allelic disorder.
  • ESRS-A - CGI-S Dystonia|ESRSA1-CGI-S Dystonia|ESRSA1-CGI-S Dystonia|ESRSA126

    extrapyramidal symptom rating scale-abbreviated (esrs-a) clinical global impression (cgi-s): dystonia.
  • ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx|ESRSA1-Dystonia: Eyes/Face/Larynx|ESRSA1-Dystonia: Eyes/Face/Larynx|ESRSA113

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: eyes, upper face, lower face, larynx.
  • ESRS-A - Dystonia: Hips/Lower Limbs/Feet|ESRSA1-Dystonia: Hips/Lower Limbs/Feet|ESRSA1-Dystonia: Hips/Lower Limbs/Feet|ESRSA115

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: hips, lower limbs, feet.
  • ESRS-A - Dystonia: Jaw|ESRSA1-Dystonia: Jaw|ESRSA1-Dystonia: Jaw|ESRSA112

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: jaw.
  • ESRS-A - Dystonia: Shoulder/Upper Limbs/Hands|ESRSA1-Dystonia: Shoulder/Up Limb/Hand|ESRSA1-Dystonia: Shoulder/Up Limb/Hand|ESRSA114

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: shoulders, upper limbs, hands.
  • ESRS-A - Dystonia: Tongue|ESRSA1-Dystonia: Tongue|ESRSA1-Dystonia: Tongue|ESRSA111

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: tongue.
  • ESRS-A - Dystonia: Trunk/Neck|ESRSA1-Dystonia: Trunk/Neck|ESRSA1-Dystonia: Trunk/Neck|ESRSA116

    extrapyramidal symptom rating scale-abbreviated (esrs-a) dystonia: trunk, neck.
  • Genetic Torsion Dystonia|Genomic torsion dystonia

    an inherited dystonia that is characterized by abnormal postures and sustained muscle contractions leading to twisting or repetitive movements.
  • Global Dystonia Severity Rating Scale Clinical Classification|GDRS|GDRS|GDRS1|GDS|Global Dystonia Severity Rating Scale

    an instrument to assess dystonia severity. it applies to 10 body regions: eyes and upper face, lower face, jaw and tongue, larynx, neck, shoulder and proximal arm (left and right), distal arm and elbow (left and right), proximal leg and pelvis (left and right), distal leg and foot (left and right) and trunk.
  • Idiopathic Torsion Dystonia

    torsion dystonia for which no underlying cause has been identified.
  • MDS-UPDRS - Painful Off-state Dystonia|UPD2-Painful Off-state Dystonia|UPD2-Painful Off-state Dystonia|UPD2406

    the movement disorder society version of the unified parkinson's disease rating scale (mds-updrs) painful off-state dystonia.
  • Non-Familial Idiopathic Dystonia|Idiopathic nonfamilial dystonia

    evidence of non-familial idiopathic dystonia.
  • Other Drug-Induced Dystonia|Other drug induced dystonia

    evidence of other drug-induced dystonia not specified elsewhere.
  • Other Dystonia|Other dystonia

    evidence of other dystonia not specified elsewhere.
  • Spasmodic Torticollis|Cervical Dystonia

    a rare movement disorder of unknown etiology, characterized by painful, involuntary turns of the head to the right, left, upwards, or downwards.
  • TH wt Allele|DYT14|DYT5b|Dystonia 14 Gene|TYH|Tyrosine Hydroxylase wt Allele

    human th wild-type allele is located in the vicinity of 11p15.5 and is approximately 8 kb in length. this allele, which encodes tyrosine 3-monooxygenase protein, is involved in tyrosine metabolism. mutation of the gene is associated with autosomal recessive segawa syndrome.
  • TOR1A wt Allele|DQ2|DYT1|Dystonia 1, Torsion (Autosomal Dominant; Torsin A) Gene|TA|TORA|Torsin A Gene|Torsin Family 1 Member A wt Allele|Torsin Family 1, Member A (Torsin A) Gene

    human tor1a wild-type allele is located in the vicinity of 9q34.11 and is approximately 11 kb in length. this allele, which encodes torsin-1a protein, is involved in chaperone activity. mutation of the gene is associated with autosomal dominant torsion dystonia 1.
  • Torsin-1A|Dystonia 1 Protein|EC 3.6.4.-|TOR1A|Torsin 1A|Torsin A|Torsin ATPase 1|Torsin ATPase-1A|Torsin Family 1 Member A

    torsin-1a (332 aa, ~38 kda) is encoded by the human tor1a gene. this protein plays a role in protein folding, maturation and localization.
  • Torsion Dystonia 6|DYT6

    an autosomal dominant condition caused by mutation(s) in the thap1 gene, encoding thap domain-containing protein 1. it is characterized by dystonic craniofacial movements, dysarthria, and dysphagia. limb involvement is common.
  • TUBB4A wt Allele|Class IVa Beta-Tubulin Gene|DYT4|Dystonia 4, Torsion (Autosomal Dominant) Gene|TUBB4|TUBB5|Tubulin Beta 4A Class IVa wt Allele|Tubulin, Beta 4 Class IVa Gene|Tubulin, Beta 4 Gene|Tubulin, Beta, 5 Gene|Tubulin, Beta, Class IVa Gene|Tubulin, Beta-4A Gene|beta-5

    human tubb4a wild-type allele is located in the vicinity of 19p13.3 and is approximately 9 kb in length. this allele, which encodes tubulin beta-4a chain protein, plays a role in microtubule structure and function. mutations in the gene are associated with hypomyelinating leukodystrophy-6 and autosomal dominant torsion dystonia-4.
  • Tyrosine Hydroxylase Deficiency|Dystonia, Dopa-Responsive, Autosomal Recessive|Parkinsonism, Infantile, Autosomal Recessive|Segawa Syndrome, Autosomal Recessive

    an autosomal recessive condition caused by mutation(s) in the th gene, encoding tyrosine 3-monooxygenase. it is characterized by onset in infancy of dopa-responsive dystonia.
  • UHDRS 1999 Version - Maximal Dystonia: LLE|UHDR1-Maximal Dystonia: LLE|UHDR1-Maximal Dystonia: LLE|UHDR111E

    unified huntington's disease rating scale 1999 version (uhdrs 1999 version) maximal dystonia-lle.
  • UHDRS 1999 Version - Maximal Dystonia: LUE|UHDR1-Maximal Dystonia: LUE|UHDR1-Maximal Dystonia: LUE|UHDR111C

    unified huntington's disease rating scale 1999 version (uhdrs 1999 version) maximal dystonia-lue.
  • UHDRS 1999 Version - Maximal Dystonia: RLE|UHDR1-Maximal Dystonia: RLE|UHDR1-Maximal Dystonia: RLE|UHDR111D

    unified huntington's disease rating scale 1999 version (uhdrs 1999 version) maximal dystonia-rle.
  • UHDRS 1999 Version - Maximal Dystonia: RUE|UHDR1-Maximal Dystonia: RUE|UHDR1-Maximal Dystonia: RUE|UHDR111B

    unified huntington's disease rating scale 1999 version (uhdrs 1999 version) maximal dystonia-rue.
  • UHDRS 1999 Version - Maximal Dystonia: Trunk|UHDR1-Maximal Dystonia: Trunk|UHDR1-Maximal Dystonia: Trunk|UHDR111A

    unified huntington's disease rating scale 1999 version (uhdrs 1999 version) maximal dystonia-trunk.
  • UPDRS - Complications of Therapy: Dyskinesias - Presence of Early Morning Dystonia|UPD1-Complications:Dyskinesias Dystonia|UPD1-Complications:Dyskinesias Dystonia|UPD135

    unified parkinson's disease rating scale (updrs) complications of therapy (in the past week); dyskinesias, presence of early morning dystonia (historical information.).
  • X-Linked Dystonia Parkinsonism|DYT3|Dystonia 3|X-Linked Dystonia-Parkinsonism|XDP

    an x-linked recessive inherited movement disorder caused by mutations in and near the taf1 gene. it is found only in people of filipino descent. it is characterized by parkinsonism and later in life the development of involuntary, sustained muscle contractions.
  • X-Linked Dystonia-Parkinsonism|DYT3|Dystonia 3|XDP

    an x-linked recessive condition caused by mutation(s) in the taf1 gene, encoding transcription initiation factor tfiid subunit 1. it is characterized by torsion dystonia and parkinsonism.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Use Additional Code

Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
  • code for adverse effect, if applicable, to identify drug T36 T50

Patient Education


Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

What is a drug interaction?

A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as gingko and blood thinners
  • Drugs and medical conditions, such as aspirin and peptic ulcers

Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.

What are side effects?

Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.

What are drug allergies?

Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.

How can I stay safe when taking medicines?

When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.


[Learn More in MedlinePlus]

Dystonia

Dystonia is a movement disorder that causes involuntary contractions of your muscles. These contractions result in twisting and repetitive movements. Sometimes they are painful.

Dystonia can affect just one muscle, a group of muscles or all of your muscles. Symptoms can include tremors, voice problems or a dragging foot. Symptoms often start in childhood. They can also start in the late teens or early adulthood. Some cases worsen over time. Others are mild.

Some people inherit dystonia. Others have it because of another disease. Researchers think that dystonia may be due to a problem in the part of the brain that handles messages about muscle contractions. There is no cure. Doctors use medicines, Botox injections, surgery, physical therapy, and other treatments to reduce or eliminate muscle spasms and pain.

NIH: National Institute of Neurological Disorders and Stroke


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.